{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:59:52Z","timestamp":1793314792393,"version":"4.5.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T00:00:00Z","timestamp":1557187200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI10\/1993"],"award-info":[{"award-number":["PI10\/1993"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13054-019-2450-5","type":"journal-article","created":{"date-parts":[[2019,5,7]],"date-time":"2019-05-07T16:55:19Z","timestamp":1557248119000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Pyroglutamic acidosis by glutathione regeneration blockage in critical patients with septic shock"],"prefix":"10.1186","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0921-2168","authenticated-orcid":false,"given":"Yenifer","family":"Gamarra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe C.","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Molina-L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Herrera-Quintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Dom\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Planells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,7]]},"reference":[{"key":"2450_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1186\/cc2175","volume":"7","author":"H Gerlach","year":"2003","unstructured":"Gerlach H, Keh D. Recent progress in sepsis epidemiology--have we learned enough? Crit Care Lond Engl. 2003;7:333\u20134.","journal-title":"Crit Care Lond Engl."},{"key":"2450_CR2","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/CCM.0000000000002255","volume":"45","author":"A Rhodes","year":"2017","unstructured":"Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2016. Crit Care Med. 2017;45:486 [cited 2018 Apr 19]. Available from: \n                    https:\/\/journals.lww.com\/ccmjournal\/Fulltext\/2017\/03000\/Surviving_Sepsis_Campaign___International.15.aspx\n                    \n                  .","journal-title":"Crit Care Med"},{"key":"2450_CR3","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315:801\u201310.","journal-title":"JAMA."},{"key":"2450_CR4","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1016\/j.bbagen.2012.10.012","volume":"1830","author":"D Morris","year":"2013","unstructured":"Morris D, Khurasany M, Nguyen T, Kim J, Guilford F, Mehta R, et al. Glutathione and infection. Biochim Biophys Acta. 2013;1830:3329\u201349.","journal-title":"Biochim Biophys Acta"},{"key":"2450_CR5","doi-asserted-by":"publisher","first-page":"L429","DOI":"10.1152\/ajplung.00159.2013","volume":"306","author":"SM Yeligar","year":"2014","unstructured":"Yeligar SM, Harris FL, Hart CM, Brown LAS. Glutathione attenuates ethanol-induced alveolar macrophage oxidative stress and dysfunction by downregulating NADPH oxidases. Am J Physiol Lung Cell Mol Physiol. 2014;306:L429\u201341.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"2450_CR6","doi-asserted-by":"publisher","first-page":"847","DOI":"10.3945\/ajcn.110.003483","volume":"94","author":"RV Sekhar","year":"2011","unstructured":"Sekhar RV, Patel SG, Guthikonda AP, Reid M, Balasubramanyam A, Taffet GE, et al. Deficient synthesis of glutathione underlies oxidative stress in aging and can be corrected by dietary cysteine and glycine supplementation. Am J Clin Nutr. 2011;94:847\u201353.","journal-title":"Am J Clin Nutr"},{"key":"2450_CR7","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1097\/01.CCM.0000089945.69588.18","volume":"31","author":"RL Paterson","year":"2003","unstructured":"Paterson RL, Galley HF, Webster NR. The effect of N-acetylcysteine on nuclear factor-kappa B activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis. Crit Care Med. 2003;31:2574\u20138.","journal-title":"Crit Care Med"},{"key":"2450_CR8","doi-asserted-by":"publisher","first-page":"560","DOI":"10.2174\/1389200216666151015114515","volume":"16","author":"T Homma","year":"2015","unstructured":"Homma T, Fujii J. Application of glutathione as anti-oxidative and anti-aging drugs. Curr Drug Metab. 2015;16:560\u201371.","journal-title":"Curr Drug Metab"},{"key":"2450_CR9","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/1750-1172-2-16","volume":"2","author":"E Ristoff","year":"2007","unstructured":"Ristoff E, Larsson A. Inborn errors in the metabolism of glutathione. Orphanet J Rare Dis. 2007;2:16 [cited 2018 Jun 26]. Available from: \n                    https:\/\/doi.org\/10.1186\/1750-1172-2-16\n                    \n                  .","journal-title":"Orphanet J Rare Dis"},{"key":"2450_CR10","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1073\/pnas.67.3.1248","volume":"67","author":"M Orlowski","year":"1970","unstructured":"Orlowski M, Meister A. The gamma-glutamyl cycle: a possible transport system for amino acids. Proc Natl Acad Sci U S A. 1970;67:1248\u201355.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2450_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.abb.2015.11.023","volume":"595","author":"M Inoue","year":"2016","unstructured":"Inoue M. Glutathionists in the battlefield of gamma-glutamyl cycle. Arch Biochem Biophys. 2016;595:61\u20133.","journal-title":"Arch Biochem Biophys"},{"key":"2450_CR12","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.clnu.2008.04.006","volume":"27","author":"M Poeze","year":"2008","unstructured":"Poeze M, Luiking YC, Breedveld P, Manders S, Deutz NEP. Decreased plasma glutamate in early phases of septic shock with acute liver dysfunction is an independent predictor of survival. Clin Nutr Edinb Scotl. 2008;27:523\u201330.","journal-title":"Clin Nutr Edinb Scotl"},{"key":"2450_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2215\/CJN.07730713","volume":"9","author":"M Emmett","year":"2014","unstructured":"Emmett M. Acetaminophen toxicity and 5-oxoproline (pyroglutamic acid): a tale of two cycles, one an ATP-depleting futile cycle and the other a useful cycle. Clin J Am Soc Nephrol. 2014;9:191\u2013200.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2450_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s12038-010-0004-8","volume":"35","author":"A Kumar","year":"2010","unstructured":"Kumar A, Bachhawat AK. A futile cycle, formed between two ATP-dependant gamma-glutamyl cycle enzymes, gamma-glutamyl cysteine synthetase and 5-oxoprolinase: the cause of cellular ATP depletion in nephrotic cystinosis? J Biosci. 2010;35:21\u20135.","journal-title":"J Biosci"},{"key":"2450_CR15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1590\/S0103-507X2010000400003","volume":"22","author":"A Coelho Neto","year":"2010","unstructured":"Coelho Neto A, Azevedo RP, Santos MBP, Galdieri L de C, D\u2019Almeida V, do AJLG, et al. Homocysteine plasma levels as a marker of clinical severity in septic patients. Rev Bras Ter Intensiva. 2010;22:327\u201332.","journal-title":"Rev Bras Ter Intensiva"},{"key":"2450_CR16","first-page":"787","volume":"76","author":"A Tsantes","year":"2010","unstructured":"Tsantes A, Tsangaris I, Nikolopoulos G, Bagos P, Kopterides P, Antonakos G, et al. The effect of homocysteine on the clinical outcomes of ventilated patients with severe sepsis. Minerva Anestesiol. 2010;76:787\u201394.","journal-title":"Minerva Anestesiol"},{"key":"2450_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1572-0241.2003.07160.x","volume":"98","author":"S Saibeni","year":"2003","unstructured":"Saibeni S, Cattaneo M, Vecchi M, Zighetti ML, Lecchi A, Lombardi R, et al. Low vitamin B(6) plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants. Am J Gastroenterol. 2003;98:112\u20137.","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"2450_CR18","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.3945\/jn.111.153056","volume":"142","author":"Lydia Sakakeeny","year":"2012","unstructured":"Sakakeeny L, Roubenoff R, Obin M, Fontes JD, Benjamin EJ, Bujanover Y, et al. Plasma pyridoxal-5-phosphate is inversely associated with systemic markers of inflammation in a population of U.S. Adults. J Nutr. 2012;142:1280\u20135. [cited 2018 Jun 28]. Available from: \n                    https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3374666\/\n                    \n                  .","journal-title":"The Journal of Nutrition"},{"key":"2450_CR19","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.clnu.2015.04.022","volume":"35","author":"J Molina-L\u00f3pez","year":"2016","unstructured":"Molina-L\u00f3pez J, Florea D, Quintero-Osso B, de la Cruz AP, Rodr\u00edguez-Elvira M, Del Pozo EP. Pyridoxal-5\u2032-phosphate deficiency is associated with hyperhomocysteinemia regardless of antioxidant, thiamine, riboflavin, cobalamine, and folate status in critically ill patients. Clin Nutr Edinb Scotl. 2016;35:706\u201312.","journal-title":"Clin Nutr Edinb Scotl."},{"key":"2450_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.clnu.2013.11.017","volume":"33","author":"T Hirose","year":"2014","unstructured":"Hirose T, Shimizu K, Ogura H, Tasaki O, Hamasaki T, Yamano S, et al. Altered balance of the aminogram in patients with sepsis - the relation to mortality. Clin Nutr Edinb Scotl. 2014;33:179\u201382.","journal-title":"Clin Nutr Edinb Scotl."},{"key":"2450_CR21","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1177\/0148607116656164","volume":"41","author":"KM Mogensen","year":"2017","unstructured":"Mogensen KM, Lasky-Su J, Rogers AJ, Baron RM, Fredenburgh LE, Rawn J, et al. Metabolites associated with malnutrition in the intensive care unit are also associated with 28-day mortality. JPEN J Parenter Enteral Nutr. 2017;41:188\u201397.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"2450_CR22","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1097\/00003246-200104000-00036","volume":"29","author":"J Lyons","year":"2001","unstructured":"Lyons J, Rauh-Pfeiffer A, Ming-Yu Y, Lu XM, Zurakowski D, Curley M, et al. Cysteine metabolism and whole blood glutathione synthesis in septic pediatric patients. Crit Care Med. 2001;29:870\u20137.","journal-title":"Crit Care Med"},{"key":"2450_CR23","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s001340000791","volume":"27","author":"I N\u00e9meth","year":"2001","unstructured":"N\u00e9meth I, Boda D. Xanthine oxidase activity and blood glutathione redox ratio in infants and children with septic shock syndrome. Intensive Care Med. 2001;27:216\u201321.","journal-title":"Intensive Care Med"},{"key":"2450_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/ajcn\/80.1.101","volume":"80","author":"AA Jackson","year":"2004","unstructured":"Jackson AA, Gibson NR, Lu Y, Jahoor F. Synthesis of erythrocyte glutathione in healthy adults consuming the safe amount of dietary protein. Am J Clin Nutr. 2004;80:101\u20137.","journal-title":"Am J Clin Nutr"},{"key":"2450_CR25","first-page":"205","volume":"13","author":"RS Lord","year":"2008","unstructured":"Lord RS, Bralley JA. Clinical applications of urinary organic acids. Part I: detoxification markers. Altern Med Rev J Clin Ther. 2008;13:205\u201315.","journal-title":"Altern Med Rev J Clin Ther"},{"key":"2450_CR26","first-page":"877","volume":"5","author":"S Geenen","year":"2013","unstructured":"Geenen S, Yates JWT, Kenna JG, Bois FY, Wilson ID, Westerhoff HV. Multiscale modelling approach combining a kinetic model of glutathione metabolism with PBPK models of paracetamol and the potential glutathione-depletion biomarkers ophthalmic acid and 5-oxoproline in humans and rats. Integr Biol Quant Biosci Nano Macro. 2013;5:877\u201388.","journal-title":"Integr Biol Quant Biosci Nano Macro"},{"key":"2450_CR27","doi-asserted-by":"publisher","first-page":"E247","DOI":"10.1152\/ajpendo.00206.2001","volume":"282","author":"Y-M Yu","year":"2002","unstructured":"Yu Y-M, Ryan CM, Fei Z-W, Lu X-M, Castillo L, Schultz JT, et al. Plasma l-5-oxoproline kinetics and whole blood glutathione synthesis rates in severely burned adult humans. Am J Physiol Endocrinol Metab. 2002;282:E247\u201358.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"4","key":"2450_CR28","doi-asserted-by":"publisher","first-page":"e12706","DOI":"10.14814\/phy2.12706","volume":"4","author":"Richard S. Lord","year":"2016","unstructured":"Lord RS. Long-term patterns of urinary pyroglutamic acid in healthy humans. Physiol Rep. 2016;4 [cited 2018 Aug 13]. Available from: \n                    https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4816898\/\n                    \n                  .","journal-title":"Physiological Reports"},{"key":"2450_CR29","doi-asserted-by":"publisher","first-page":"E868","DOI":"10.1152\/ajpendo.2000.278.5.E868","volume":"278","author":"CC Metges","year":"2000","unstructured":"Metges CC, Yu YM, Cai W, Lu XM, Wong S, Regan MM, et al. Oxoproline kinetics and oxoproline urinary excretion during glycine- or sulfur amino acid-free diets in humans. Am J Physiol Endocrinol Metab. 2000;278:E868\u201376.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2450_CR30","first-page":"3927","volume":"60","author":"S Li","year":"2000","unstructured":"Li S, Yan T, Yang JQ, Oberley TD, Oberley LW. The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase. Cancer Res. 2000;60:3927\u201339.","journal-title":"Cancer Res"},{"key":"2450_CR31","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/S0891-5849(02)01016-X","volume":"33","author":"F Antunes","year":"2002","unstructured":"Antunes F, Han D, Cadenas E. Relative contributions of heart mitochondria glutathione peroxidase and catalase to H2O2 detoxification in in vivo conditions. Free Radic Biol Med. 2002;33:1260\u20137.","journal-title":"Free Radic Biol Med"},{"key":"2450_CR32","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/ped.12698","volume":"57","author":"A Asci","year":"2015","unstructured":"Asci A, Surmeli-Onay O, Erkekoglu P, Yigit S, Yurdakok M, Kocer-Gumusel B. Oxidant and antioxidant status in neonatal proven and clinical sepsis according to selenium status. Pediatr Int Off J Jpn Pediatr Soc. 2015;57:1131\u20137.","journal-title":"Pediatr Int Off J Jpn Pediatr Soc"},{"key":"2450_CR33","first-page":"338","volume":"43","author":"X Forceville","year":"2009","unstructured":"Forceville X, Mostert V, Pierantoni A, Vitoux D, Le Toumelin P, Plouvier E, et al. Selenoprotein P, rather than glutathione peroxidase, as a potential marker of septic shock and related syndromes. Eur Surg Res Eur Chir Forsch Rech Chir Eur. 2009;43:338\u201347.","journal-title":"Eur Surg Res Eur Chir Forsch Rech Chir Eur"},{"key":"2450_CR34","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1097\/00003246-199809000-00021","volume":"26","author":"X Forceville","year":"1998","unstructured":"Forceville X, Vitoux D, Gauzit R, Combes A, Lahilaire P, Chappuis P. Selenium, systemic immune response syndrome, sepsis, and outcome in critically ill patients. Crit Care Med. 1998;26:1536\u201344.","journal-title":"Crit Care Med"},{"key":"2450_CR35","doi-asserted-by":"publisher","first-page":"2025S","DOI":"10.3945\/ajcn.2009.27230F","volume":"89","author":"K Ashton","year":"2009","unstructured":"Ashton K, Hooper L, Harvey LJ, Hurst R, Casgrain A, Fairweather-Tait SJ. Methods of assessment of selenium status in humans: a systematic review. Am J Clin Nutr. 2009;89:2025S\u201339S.","journal-title":"Am J Clin Nutr"},{"key":"2450_CR36","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.clnu.2013.01.005","volume":"32","author":"FA Stefanowicz","year":"2013","unstructured":"Stefanowicz FA, Talwar D, O\u2019Reilly DSJ, Dickinson N, Atkinson J, Hursthouse AS, et al. Erythrocyte selenium concentration as a marker of selenium status. Clin Nutr Edinb Scotl. 2013;32:837\u201342.","journal-title":"Clin Nutr Edinb Scotl."},{"issue":"Suppl 1","key":"2450_CR37","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jtemb.2007.09.021","volume":"21","author":"X Forceville","year":"2007","unstructured":"Forceville X. Effects of high doses of selenium, as sodium selenite, in septic shock patients a placebo-controlled, randomized, double-blind, multi-center phase II study--selenium and sepsis. J Trace Elem Med Biol Organ Soc Miner Trace Elem GMS. 2007;21(Suppl 1):62\u20135.","journal-title":"J Trace Elem Med Biol Organ Soc Miner Trace Elem GMS"},{"key":"2450_CR38","first-page":"524","volume":"27","author":"E Mill\u00e1n Adame","year":"2012","unstructured":"Mill\u00e1n Adame E, Florea D, S\u00e1ez P\u00e9rez L, Molina L\u00f3pez J, L\u00f3pez-Gonz\u00e1lez B, P\u00e9rez de la Cruz A, et al. Deficient selenium status of a healthy adult Spanish population. Nutr Hosp. 2012;27:524\u20138.","journal-title":"Nutr Hosp"},{"key":"2450_CR39","first-page":"214","volume":"10","author":"OA Levander","year":"1997","unstructured":"Levander OA. Selenium requirements as discussed in the 1996 joint FAO\/IAEA\/WHO expert consultation on trace elements in human nutrition. Biomed Environ Sci BES. 1997;10:214\u20139.","journal-title":"Biomed Environ Sci BES"},{"key":"2450_CR40","doi-asserted-by":"publisher","first-page":"R92","DOI":"10.1186\/cc13860","volume":"18","author":"NA Costa","year":"2014","unstructured":"Costa NA, Gut AL, Pimentel JAC, Cozzolino SMF, Azevedo PS, Fernandes AAH, et al. Erythrocyte selenium concentration predicts intensive care unit and hospital mortality in patients with septic shock: a prospective observational study. Crit Care Lond Engl. 2014;18:R92.","journal-title":"Crit Care Lond Engl"},{"key":"2450_CR41","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1186\/s13054-016-1529-5","volume":"20","author":"W Manzanares","year":"2016","unstructured":"Manzanares W, Lemieux M, Elke G, Langlois PL, Bloos F, Heyland DK. High-dose intravenous selenium does not improve clinical outcomes in the critically ill: a systematic review and meta-analysis. Crit Care Lond Engl. 2016;20:356.","journal-title":"Crit Care Lond Engl."},{"key":"2450_CR42","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/cc5975","volume":"11","author":"DK Heyland","year":"2007","unstructured":"Heyland DK. Selenium supplementation in critically ill patients: can too much of a good thing be a bad thing. Crit Care Lond Engl. 2007;11:153.","journal-title":"Crit Care Lond Engl."},{"key":"2450_CR43","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1089\/ars.2010.3586","volume":"15","author":"E Lubos","year":"2011","unstructured":"Lubos E, Loscalzo J, Handy DE. Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal. 2011;15:1957\u201397 [cited 2018 Jun 21]. Available from: \n                    https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3159114\/\n                    \n                  .","journal-title":"Antioxid Redox Signal"},{"key":"2450_CR44","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2174\/1567202610666131211111012","volume":"11","author":"AV Steckert","year":"2014","unstructured":"Steckert AV, de Castro AA, Quevedo J, Dal-Pizzol F. Sepsis in the central nervous system and antioxidant strategies with N-acetylcysteine, vitamins and statins. Curr Neurovasc Res. 2014;11:83\u201390.","journal-title":"Curr Neurovasc Res"},{"key":"2450_CR45","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jss.2007.03.072","volume":"145","author":"HZ Toklu","year":"2008","unstructured":"Toklu HZ, Tunali Akbay T, Velioglu-Ogunc A, Ercan F, Gedik N, Keyer-Uysal M, et al. Silymarin, the antioxidant component of Silybum marianum, prevents sepsis-induced acute lung and brain injury. J Surg Res. 2008;145:214\u201322.","journal-title":"J Surg Res"},{"key":"2450_CR46","first-page":"738","volume":"89","author":"O Ellouze","year":"2011","unstructured":"Ellouze O, Frikha N, Ouerghi S, Mestiri T, Salah Ben Ammar M. N-acetylcysteine in septic shock. Tunis Med. 2011;89:738\u201344.","journal-title":"Tunis Med"},{"key":"2450_CR47","first-page":"521","volume":"56","author":"K Winiarska","year":"2002","unstructured":"Winiarska K, Drozak J. Glutathione in therapy. Postepy Hig Med Dosw. 2002;56:521\u201336.","journal-title":"Postepy Hig Med Dosw"},{"key":"2450_CR48","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/hep.23267","volume":"51","author":"C Saito","year":"2010","unstructured":"Saito C, Zwingmann C, Jaeschke H. Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N-acetylcysteine. Hepatology. 2010;51:246\u201354.","journal-title":"Hepatology"},{"key":"2450_CR49","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.clnu.2014.11.014","volume":"34","author":"KAK Tanaka","year":"2015","unstructured":"Tanaka KAK, Kurihara S, Shibakusa T, Chiba Y, Mikami T. Cystine improves survival rates in a LPS-induced sepsis mouse model. Clin Nutr Edinb Scotl. 2015;34:1159\u201365.","journal-title":"Clin Nutr Edinb Scotl."},{"key":"2450_CR50","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1007\/s00431-015-2585-6","volume":"174","author":"SL Hulley","year":"2015","unstructured":"Hulley SL, Perring J, Manning N, Olpin S, Yap S. Transient 5-oxoprolinuria: unusually high anion gap acidosis in an infant. Eur J Pediatr. 2015;174:1685\u20138.","journal-title":"Eur J Pediatr"},{"key":"2450_CR51","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1097\/00003246-200006000-00018","volume":"28","author":"GA Dempsey","year":"2000","unstructured":"Dempsey GA, Lyall HJ, Corke CF, Scheinkestel CD. Pyroglutamic acidemia: a cause of high anion gap metabolic acidosis. Crit Care Med. 2000;28:1803\u20137.","journal-title":"Crit Care Med"},{"key":"2450_CR52","doi-asserted-by":"crossref","unstructured":"O\u2019Brien LMN, Hooper M, Flemmer M, Marik PE. Chronic acetaminophen ingestion resulting in severe anion gap metabolic acidosis secondary to 5-oxoproline accumulation: an under diagnosed phenomenon. BMJ Case Rep. 2012;2012 [cited 2018 Nov 25]. Available from: \n                    https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3391392\/\n                    \n                  .","DOI":"10.1136\/bcr.03.2012.6020"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-019-2450-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13054-019-2450-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-019-2450-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T23:18:23Z","timestamp":1588720703000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-019-2450-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,7]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2450"],"URL":"https:\/\/doi.org\/10.1186\/s13054-019-2450-5","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,7]]},"assertion":[{"value":"16 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Ethical Committee of the hospital and informed consent was obtained from the patients or their family who had agreed to participate in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"162"}}